The National Institutes of Health chronic prostatitis symptom index: Development and validation of a new outcome measure

被引:728
作者
Litwin, MS [1 ]
McNaughton-Collins, M
Fowler, FJ
Nickel, JC
Calhoun, EA
Pontari, MA
Alexander, RB
Farrar, JT
O'Leary, MP
机构
[1] Univ Calif Los Angeles, Dept Urol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Hlth Serv, Los Angeles, CA USA
[3] Massachusetts Gen Hosp, Gen Med Unit, Boston, MA 02114 USA
[4] Univ Massachusetts, Survey Res Ctr, Boston, MA 02125 USA
[5] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Urol Surg, Boston, MA USA
[6] Queens Univ, Dept Urol, Kingston, ON, Canada
[7] Northwestern Univ, Sch Med, Inst Hlth Serv Res & Hlth Policy Studies, Chicago, IL USA
[8] Northwestern Univ, Sch Med, Dept Urol, Chicago, IL 60611 USA
[9] Temple Univ, Sch Med, Dept Urol, Philadelphia, PA 19122 USA
[10] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[11] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA
关键词
prostatitis; pain; pelvis; quality of life; health status;
D O I
10.1016/S0022-5347(05)68562-X
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Chronic abacterial prostatitis is a syndrome characterized by pelvic pain and voiding symptoms, which is poorly defined, poorly understood, poorly treated and bothersome. Research and clinical efforts to help men with this syndrome have been hampered by the absence of a widely accepted, reliable and valid instrument to measure symptoms and quality of life impact. We developed a psychometrically valid index of symptoms and quality of life impact for men with chronic prostatitis. Materials and Methods: We conducted a structured literature review of previous work to provide a foundation for the new instrument. We then conducted a series of focus groups comprising chronic prostatitis patients at 4 centers in North America, in which we identified the most important symptoms and effects of the condition. The results were used to create an initial draft of 55 questions that were used for formal cognitive testing on chronic prostatitis patients at the same centers. After expert panel review formal validation testing of a revised 21-item draft was performed in a diverse group of chronic prostatitis patients and 2 control groups of benign prostatic hyperplasia patients and healthy men. Based on this validation study, the index was finalized. Results: Analysis yielded an index of 9 items that address 3 different aspects of the chronic prostatitis experience. The primary component was pain, which we captured in 4 items focused on location, severity and frequency. Urinary function, another important component of symptoms, was captured in 2 items (1 irritative and 1 obstructive). Quality of life impact was captured with 3 items about the effect of symptoms on daily activities. The 9 items had high test-retest reliability (r = 0.83 to 0.93) and internal consistency (alpha = 0.86 to 0.91). All but the urinary items discriminated well between men with and without chronic prostatitis. Conclusions: The National Institutes of Health chronic prostatitis symptom index provides a valid outcome measure for men with chronic prostatitis. The index is psychometrically robust, easily self-administered and highly discriminative. It was formally developed and psychometrically validated, and may be useful in clinical practice as well as research protocols.
引用
收藏
页码:369 / 375
页数:7
相关论文
共 50 条
[21]   Incidence and clinical characteristics of National Institutes of Health type III prostatitis in the community [J].
Clemens, JQ ;
Meenan, RT ;
Rosetti, MCO ;
Gao, SY ;
Calhoun, EA .
JOURNAL OF UROLOGY, 2005, 174 (06) :2319-2322
[22]   Development and validation of the Child Hemophilia Treatment Experience Measure: A new observer-reported outcome measure [J].
Brod, Meryl ;
Bushnell, Donald M. ;
Busk, Anne Kirstine ;
Neergaard, Jesper Skov .
HAEMOPHILIA, 2025, 31 (01) :48-62
[23]   Surgical management of National Institutes of Health category II chronic bacterial prostatitis: a case series and scoping review of the literature [J].
Orji, Peace U. ;
Khooblall, Prajit ;
Doolittle, Jonathan ;
Lundy, Scott D. ;
Shoskes, Daniel .
TRANSLATIONAL ANDROLOGY AND UROLOGY, 2023, 12 (10) :1581-1588
[24]   Development and content validity of a hemodialysis symptom patient-reported outcome measure [J].
Flythe, Jennifer E. ;
Dorough, Adeline ;
Narendra, Julia H. ;
Wingard, Rebecca L. ;
Dalrymple, Lorien S. ;
DeWalt, Darren A. .
QUALITY OF LIFE RESEARCH, 2019, 28 (01) :253-265
[25]   The Spinal Muscular Atrophy Health Index: Italian validation of a disease-specific outcome measure [J].
Sansone, Valeria A. ;
Pirola, Alice ;
Lizio, Andrea ;
Greco, Lucia Catherine ;
Coratti, Giorgia ;
Casiraghi, Jacopo ;
Pane, Marika ;
Pera, Maria Carmela ;
Italiano, Cristina ;
Messina, Sonia ;
Pozzi, Susanna ;
Sframeli, Maria ;
D'Amico, Adele ;
Bertini, Enrico ;
Bruno, Claudio ;
Mauro, Luca ;
Salmin, Francesca ;
Stancanelli, Claudia ;
Pedemonte, Marina ;
Albamonte, Emilio ;
Zizzi, Christine ;
Heatwole, Chad ;
Mercuri, Eugenio .
NEUROMUSCULAR DISORDERS, 2021, 31 (05) :409-418
[26]   Development and validation of an instrument to measure asthma symptom control in children [J].
Zorc, Joseph J. ;
Pawlowski, Nicholas A. ;
Allen, Julian L. ;
Bryant-Stephens, Tyra ;
Winston, Marcia ;
Angsuco, Cherrie ;
Shea, Judy A. .
JOURNAL OF ASTHMA, 2006, 43 (10) :753-758
[27]   Validation of The National Institutes of Health (NIH) Scale for Oral Chronic Graft-versus-Host Disease (cGVHD) [J].
Elad, Sharon ;
Zeevi, Itai ;
Or, Reuven ;
Resnick, Igor B. ;
Dray, Lilian ;
Shapira, Michael Y. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (01) :62-69
[28]   The role of National Institutes of Health category IV prostatitis in accurately staging the newly diagnosed prostate cancer [J].
Aglamis, E. ;
Tasdemir, C. ;
Ceylan, C. .
IRISH JOURNAL OF MEDICAL SCIENCE, 2013, 182 (03) :463-467
[29]   The prevalence of men with National Institutes of Health category IV prostatitis and association with serum prostate specific antigen [J].
Carver, BS ;
Bozeman, CB ;
Williams, BJ ;
Venable, DD .
JOURNAL OF UROLOGY, 2003, 169 (02) :589-591
[30]   Prospective identification of national institutes of health category IV prostatitis in men with elevated prostate specific antigen [J].
Potts, JM .
JOURNAL OF UROLOGY, 2000, 164 (05) :1550-1553